Civica Rx signs agreement with Thermo Fischer Scientific

Civica Rx announced it has signed a seven-year term agreement with Thermo Fischer Scientific to develop and manufacture medications with Civica as the owner of the regulatory pathway.   By partnering with Thermo Fisher to develop Civica-owned Abbreviated New Drug Applications (ANDAs), Civica will begin to build its internal pipeline of medications for use in emergency and critical care in the United States. Read article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.